Eric Topol Discusses Scripps’ 20-Year Study to Link Genomic Data With Lifestyle Changes | GenomeWeb

The Scripps Translational Science Institute announced last week that it is joining forces with Navigenics, Affymetrix, and Microsoft on a 20-year study investigating whether arming individuals with their personal genomic information will motivate them to make preventative lifestyle changes or seek medical care.

The study aims to enroll 10,000 participants from within Scripps Health, a $2 billion nonprofit community health system based in San Diego, by offering genome scans to its employees, families, and friends.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.